Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
-
Search results from the "OB_Rx" table for query
on "022083."
| Active Ingredient: | RIVASTIGMINE |
| Dosage Form;Route: | FILM, EXTENDED RELEASE; TRANSDERMAL |
| Proprietary Name: | EXELON |
| Applicant: | NOVARTIS |
| Strength: | 4.6MG/24HR |
| Application Number: | N022083 |
| Product Number: | 001 |
| Approval Date: | Jul 6, 2007 |
| Reference Listed Drug | No |
| RX/OTC/DISCN: | RX |
| TE Code: | |
| Patent and Exclusivity Info for this product: | View |
|
|
|
| Active Ingredient: | RIVASTIGMINE |
| Dosage Form;Route: | FILM, EXTENDED RELEASE; TRANSDERMAL |
| Proprietary Name: | EXELON |
| Applicant: | NOVARTIS |
| Strength: | 9.5MG/24HR |
| Application Number: | N022083 |
| Product Number: | 002 |
| Approval Date: | Jul 6, 2007 |
| Reference Listed Drug | Yes |
| RX/OTC/DISCN: | RX |
| TE Code: | |
| Patent and Exclusivity Info for this product: | View |
|
|
|
| Active Ingredient: | RIVASTIGMINE |
| Dosage Form;Route: | FILM, EXTENDED RELEASE; TRANSDERMAL |
| Proprietary Name: | EXELON |
| Applicant: | NOVARTIS |
| Strength: | 13.3MG/24HR |
| Application Number: | N022083 |
| Product Number: | 005 |
| Approval Date: | Aug 31, 2012 |
| Reference Listed Drug | No |
| RX/OTC/DISCN: | RX |
| TE Code: | |
| Patent and Exclusivity Info for this product: | View |
|
|
|
Return to Electronic Orange Book Home Page
| FDA/Center for Drug Evaluation and Research |
| Office of Generic Drugs |
| Division of Labeling and Program Support |
| Update Frequency: |
| Orange Book Data - Monthly |
| Generic Drug Product Information & Patent Information - Daily |
| Orange Book Data Updated Through April, 2013 |
| Patent and Generic Drug Product Data Last Updated: May 17, 2013 |
-
